Keywords: Hyperpolarized MR (Gas), Hyperpolarized MR (Non-Gas)
Motivation: Hyperpolarized [2-13C]pyruvate for MR metabolic imaging has low SNR due to shorter T1 in H2O compared to [1-13C]pyruvate. Dissolving in D2O can enhance T1 and SNR.
Goal(s): We aimed to increase T1 for hyperpolarized [2-13C]pyruvate in-vivo studies using D2O dissolutions to improve metabolic imaging of brain glycolysis and oxidative metabolism.
Approach: T1 and polarization levels of hyperpolarized [2-13C]pyruvate, produced for human studies in H2O or D2O, were analyzed using NMR spectroscopy.
Results: Dissolving hyperpolarized [2-13C]pyruvate in D2O increased T1 by 1.4-fold and polarization by a 1.8-fold after ~2 minutes in vitro, with in-vivo brain data, indicating potential for better imaging quality.
Impact: Dissolving hyperpolarized [2-13C]pyruvate in D2O instead of H2O increased T1, yielding higher polarization for human MRI studies. This approach is expected to improve the quality of hyperpolarized [2-13C]pyruvate MRI, enabling more accurate assessments of oxidative & glycolytic metabolism of pyruvate.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords